GL1X · GenesisL1 explorer

MolNFT v1 · #46929 · protein

Structure of igf-1R kinase domain complexed with a benzimidazole inhibitor

2OJ9 · Insulin-like growth factor 1 receptor precursor (ec…: “Structure of igf-1R kinase domain complexed with a benzimidazole inhibitor”. X-ray diffraction, 1 ligand (BMI), 3 pockets (best druggability 0.72). MolNFT v1 #46929 on…

PDB
2OJ9
Type
protein
Length
295 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin-like growth factor 1 receptor precursor (ec 2.7.10.1) (insulin-like growth factor…
EC
2.7.1.112
UniProt
P08069
Ligands
BMI
Pockets
3 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInsulin-like growth factor 1 receptor precursor (ec 2.7.10.1) (insulin-like growth factor I receptor) (igf- I receptor) (CD221 antigen) (EC 2.7.1.112)protein29538% helix, 19% strandP08069

Ligands and binding sites

  • BMI · 3-[5-(1H-imidazol-1-yl)-7-methyl-1H-benzimidazol-2-yl]-4-[(pyridin-2-ylmethyl)amino]pyridin-2(1H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13670.720.8346BMI
2710.360.7618empty
31150.340.7221empty

Compared structures

  • 2OJ9 · Structure of IGF-1R kinase domain complexed with a benzimidazole inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P08069 · AlphaFold monomer V2.0 prediction for insulin-like growth factor 1 receptor (P08069) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.